Nrgene Technologies Ltd (NRGN) — Capital Reinvestment Ratio

Latest as of December 2025: 0.45x

Nrgene Technologies Ltd (NRGN) has a Capital Reinvestment Ratio of 0.45x as of December 2025, meaning it reinvests 0% of its operating cash flow (ILA1.73 Million) in capital expenditures (ILA775.50K). See NRGN net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.45x

Capex / Operating Cash Flow

Operating Cash Flow

ILA1.73 Million

ILA

Capital Expenditures

ILA775.50K

ILA

Data as of

Dec 2025

Most recent filing

Nrgene Technologies Ltd Capital Reinvestment Ratio (2025–2025)

This chart tracks Nrgene Technologies Ltd's Capital Reinvestment Ratio across 1 annual periods. Check Nrgene Technologies Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Nrgene Technologies Ltd (2025–2025)

Year-by-year Capital Reinvestment Ratio for Nrgene Technologies Ltd from 2025 to 2025. For live market cap and broader valuation context, see how much is Nrgene Technologies Ltd worth.

Year	Reinvestment Ratio	Operating CF (ILA)	Capital Expenditures	YoY Change
2025	0.92x	ILA855.00K	ILA783.00K	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow